VPAResearch

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.


Research Reports By VPAResearch

Found 4661 publications
Ornithine Transcarbamylase Deficiency Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 40 pages
Hyperphosphatemia In Chronic Kidney Disease Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 58 pages
Choroidal Neovascularization Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 61 pages
Adrenocortical Carcinoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 56 pages
Thrombotic Thrombocytopenic Purpura Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 41 pages
Polycythemia Vera Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 48 pages
Macular Edema Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 51 pages
Essential Thrombocythemia Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 59 pages
Axial Spondyloarthritis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 50 pages
Wilson Disease Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 51 pages
Mucopolysaccharidosis I (Hurler Syndrome ) Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 72 pages
Fibrosarcoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 62 pages
Becker Muscular Dystrophy Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 45 pages
Prosthetic joint infections Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 46 pages
Oligodendroglioma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 75 pages
Graves Ophthalmopathy Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 40 pages
Chemotherapy Induced Anemia Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 52 pages
Rhino-Conjunctivitis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 71 pages
Uveal Melanoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 112 pages
Peripheral Nerve Sheath Tumor Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 76 pages
Kaposi Sarcoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 86 pages
Degenerative Disc Disease Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 60 pages
Alpha-1 Antitrypsin Deficiency Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 84 pages
Retinal Vein Occlusion Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 87 pages
Neurofibromatoses Type 2 Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 46 pages
Gaucher Disease Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 65 pages
Bronchiectasis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 72 pages
Optic Neuropathy Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 48 pages
High-Grade Glioma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 146 pages
Chondrosarcoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 79 pages
Acute Respiratory Distress Syndrome Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 101 pages
Systemic Juvenile Idiopathic Arthritis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 42 pages
Vulvar Cancer Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 70 pages
Polycystic Kidney Disease Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 82 pages
Leiomyosarcoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 124 pages
Ependymoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 63 pages
Ankylosing Spondylitis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 120 pages
Merkel Cell Carcinoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 121 pages
Fibrodysplasia Ossificans Progressiva Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 60 pages
B-Cell Chronic Lymphocytic Leukemia Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 145 pages
Primary Immune Deficiency Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 71 pages
Rhabdomyosarcoma Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 112 pages
Ocular Hypertension Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 121 pages
Gouty Arthritis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 130 pages
Cataract Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 46 pages
Osteonecrosis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 40 pages
Juvenile Macular Degeneration Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 81 pages
Crigler-Najjar Syndrome Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 40 pages
Allergic Rhinitis Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 119 pages
Uterine Fibroids Pipeline Analysis and Outlook, 2019 US$ 1,599.00 May, 2019 75 pages
1 2 3 4 5 ... 94
Skip to top